comprimé pelliculé sécable à libération prolongée clinical trials

AUDIOWOLF: A phase II, open-label, efficacy study of daily administration of sodium valproate in patients clinically affected by Wolfram syndrome due to monogenic mutation

This study is looking at whether a daily medication called sodium valproate can help protect the hearing of people with Wolfram syndrome. Researchers will measure hearing over three years using special tests to see if the medication can prevent it from getting worse.